Neoplasms, Unknown Primary
"Neoplasms, Unknown Primary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metastases in which the tissue of origin is unknown.
| Descriptor ID |
D009382
|
| MeSH Number(s) |
C04.697.650.895 C23.550.727.650.895
|
| Concept/Terms |
Neoplasms, Unknown Primary- Neoplasms, Unknown Primary
- Occult Primary Neoplasms
- Neoplasms, Occult Primary
- Neoplasm, Occult Primary
- Occult Primary Neoplasm
- Primary Neoplasm, Occult
- Primary Neoplasms, Occult
- Unknown Primary Neoplasms
- Neoplasm, Unknown Primary
- Primary Neoplasm, Unknown
- Primary Neoplasms, Unknown
- Unknown Primary Neoplasm
Unknown Primary Tumors- Unknown Primary Tumors
- Primary Tumor, Unknown
- Primary Tumors, Unknown
- Tumor, Unknown Primary
- Tumors, Unknown Primary
- Unknown Primary Tumor
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Unknown Primary".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Unknown Primary".
This graph shows the total number of publications written about "Neoplasms, Unknown Primary" by people in this website by year, and whether "Neoplasms, Unknown Primary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Unknown Primary" by people in Profiles.
-
van der Strate I, Kazemzadeh F, Nagtegaal ID, Robbrecht D, van de Wouw A, Padilla CS, Duijts S, Esteller M, Greco FA, Pavlidis N, Qaseem A, Snaebjornsson P, van Zanten SV, Loef C. International consensus on the initial diagnostic workup of cancer of unknown primary. Crit Rev Oncol Hematol. 2023 Jan; 181:103868.
-
Ripa V, Smith F, Goodman JW. Case of metastatic epithelioid haemangioendothelioma from an unknown primary site associated with membranous nephropathy and hypercoagulable state. BMJ Case Rep. 2022 Aug 22; 15(8).
-
Cornman-Homonoff J, Miller ZA, Smirniotopoulos J, May BJ, Winokur RS, Pua BB, Schiffman MH. Preoperative Percutaneous Microwave Ablation of Long Bone Metastases Using a Parallel Medullary Approach for Reduction of Operative Blood Loss. J Vasc Interv Radiol. 2017 07; 28(7):1069-1071.
-
Sohn G, Son BH, Lee SJ, Kang EY, Jung SH, Cho SH, Baek S, Lee YR, Kim HJ, Ko BS, Lee JW, Ahn SH. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study. J Surg Oncol. 2014 Sep; 110(3):270-4.
-
Dalal MD, Morgans CW, Duvoisin RM, Gamboa EA, Jeffrey BG, Garg SJ, Chan CC, Sen HN. Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. Ophthalmology. 2013 Dec; 120(12):2560-2564.
-
Durmus K, Rangarajan SV, Old MO, Agrawal A, Teknos TN, Ozer E. Transoral robotic approach to carcinoma of unknown primary. Head Neck. 2014 Jun; 36(6):848-52.
-
Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Huang VJ, Erlander MG, Brachtel EF, Dry SM. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors. Mod Pathol. 2014 Jan; 27(1):44-54.
-
Kaliki S, Eagle RC, Shields CL, Shields JA. Ciliochoroidal metastasis as the initial manifestation of an occult soft-tissue extraosseous sarcoma in a 10-year-old girl. J AAPOS. 2013 Apr; 17(2):217-20.
-
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer. J Surg Oncol. 2012 Jul 1; 106(1):24-30.
-
Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol. 2010 Jul 10; 28(20):3388-404.